scout
News|Videos|April 29, 2024

Predictive Biomarkers for Treatment With Amivantamab Plus Lazertinib Among EGFR-Mutated NSCLC in the Post-Osimertinib Setting: Analysis of Tissue IHC and ctDNA NGS

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME